APG Asset Management N.V. boosted its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 260.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 472,410 shares of the financial services provider's stock after purchasing an additional 341,238 shares during the period. APG Asset Management N.V. owned 0.13% of CME Group worth $105,947,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of CME. Vanguard Group Inc. increased its holdings in shares of CME Group by 1.0% in the fourth quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock valued at $7,952,273,000 after purchasing an additional 326,623 shares in the last quarter. Geode Capital Management LLC raised its position in shares of CME Group by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock worth $1,946,717,000 after acquiring an additional 104,697 shares during the last quarter. Norges Bank acquired a new position in shares of CME Group during the fourth quarter valued at $1,107,389,000. FIL Ltd boosted its holdings in CME Group by 1.5% in the fourth quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock valued at $947,821,000 after acquiring an additional 61,908 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in CME Group in the fourth quarter worth about $871,063,000. Institutional investors own 87.75% of the company's stock.
Insider Activity at CME Group
In other CME Group news, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the sale, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Howard J. Siegel sold 10,000 shares of the stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the transaction, the director now owns 21,873 shares of the company's stock, valued at approximately $5,686,980. This represents a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 27,076 shares of company stock valued at $6,871,496. 0.30% of the stock is owned by insiders.
Analyst Ratings Changes
Several research analysts have recently issued reports on CME shares. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $269.00 target price on shares of CME Group in a research note on Thursday, April 3rd. Piper Sandler lifted their target price on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a report on Tuesday, April 8th. Erste Group Bank raised CME Group to a "strong-buy" rating in a research note on Monday, March 17th. Oppenheimer lifted their price objective on CME Group from $269.00 to $279.00 and gave the stock an "outperform" rating in a research note on Friday. Finally, Bank of America increased their target price on CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research note on Wednesday, April 2nd. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $247.47.
Get Our Latest Stock Report on CME Group
CME Group Stock Up 1.2 %
CME traded up $3.15 during trading on Friday, reaching $261.54. The company had a trading volume of 2,756,965 shares, compared to its average volume of 2,136,648. The company has a market cap of $94.25 billion, a P/E ratio of 27.05, a PEG ratio of 6.76 and a beta of 0.43. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $273.42. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The business's fifty day moving average price is $255.22 and its 200 day moving average price is $239.10.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were issued a dividend of $1.25 per share. The ex-dividend date was Friday, March 7th. This is an increase from CME Group's previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.91%. CME Group's dividend payout ratio (DPR) is presently 51.71%.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report